2/10
08:00 am
srrk
Scholar Rock to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026
Low
Report
Scholar Rock to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026
2/1
02:53 am
srrk
Scholar Rock Chief Scientific Officer Conducts Multiple Sales Throughout January 2026 [Yahoo! Finance]
Medium
Report
Scholar Rock Chief Scientific Officer Conducts Multiple Sales Throughout January 2026 [Yahoo! Finance]
1/26
07:03 am
srrk
Scholar Rock (NASDAQ:SRRK) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Low
Report
Scholar Rock (NASDAQ:SRRK) had its "buy" rating reaffirmed by analysts at HC Wainwright.
1/16
04:15 pm
srrk
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
1/13
05:44 am
srrk
Scholar Rock (NASDAQ:SRRK) was upgraded by analysts at Citigroup Inc. to a "strong-buy" rating.
Low
Report
Scholar Rock (NASDAQ:SRRK) was upgraded by analysts at Citigroup Inc. to a "strong-buy" rating.
1/12
07:20 am
srrk
Scholar Rock Highlights 2026 Strategic Priorities [Yahoo! Finance]
Low
Report
Scholar Rock Highlights 2026 Strategic Priorities [Yahoo! Finance]
1/12
07:00 am
srrk
Scholar Rock Highlights 2026 Strategic Priorities
Low
Report
Scholar Rock Highlights 2026 Strategic Priorities
1/9
07:18 am
srrk
Scholar Rock (NASDAQ:SRRK) is now covered by analysts at Citigroup Inc.. They set a "buy" rating on the stock.
Low
Report
Scholar Rock (NASDAQ:SRRK) is now covered by analysts at Citigroup Inc.. They set a "buy" rating on the stock.
1/9
06:10 am
srrk
Scholar Rock (NASDAQ:SRRK) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.
Low
Report
Scholar Rock (NASDAQ:SRRK) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.
1/7
03:00 am
srrk
Scholar Rock (NASDAQ:SRRK) is now covered by analysts at UBS Group AG. They set a "buy" rating on the stock.
Medium
Report
Scholar Rock (NASDAQ:SRRK) is now covered by analysts at UBS Group AG. They set a "buy" rating on the stock.
1/6
12:49 am
srrk
Scholar Rock: Apitegromab's Path Forward Remains Intact, Maintaining Buy Rating [Seeking Alpha]
Medium
Report
Scholar Rock: Apitegromab's Path Forward Remains Intact, Maintaining Buy Rating [Seeking Alpha]
1/5
08:35 am
srrk
Scholar Rock to Present at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Low
Report
Scholar Rock to Present at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
1/5
08:00 am
srrk
Scholar Rock to Present at the 44th Annual J.P. Morgan Healthcare Conference
Low
Report
Scholar Rock to Present at the 44th Annual J.P. Morgan Healthcare Conference
12/17
07:06 am
srrk
Scholar Rock (NASDAQ:SRRK) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
Low
Report
Scholar Rock (NASDAQ:SRRK) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
12/13
10:57 am
srrk
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12/11
10:04 am
srrk
Scholar Rock (NASDAQ:SRRK) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
Low
Report
Scholar Rock (NASDAQ:SRRK) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
12/4
01:41 pm
srrk
Scholar Rock (SRRK) valuation after FDA manufacturing update and apitegromab resubmission plans [Yahoo! Finance]
Low
Report
Scholar Rock (SRRK) valuation after FDA manufacturing update and apitegromab resubmission plans [Yahoo! Finance]
12/3
03:42 pm
srrk
Scholar Rock Holding Corporation (SRRK) Presents at Citi Annual Global Healthcare Conference 2025 Transcript [Seeking Alpha]
Low
Report
Scholar Rock Holding Corporation (SRRK) Presents at Citi Annual Global Healthcare Conference 2025 Transcript [Seeking Alpha]
11/20
06:03 am
srrk
Scholar Rock (NASDAQ:SRRK) was upgraded by analysts at Wolfe Research to a "strong-buy" rating.
Medium
Report
Scholar Rock (NASDAQ:SRRK) was upgraded by analysts at Wolfe Research to a "strong-buy" rating.
11/18
11:04 am
srrk
Scholar Rock (NASDAQ:SRRK) had its price target raised by analysts at JPMorgan Chase & Co. from $46.00 to $47.00. They now have an "overweight" rating on the stock.
Medium
Report
Scholar Rock (NASDAQ:SRRK) had its price target raised by analysts at JPMorgan Chase & Co. from $46.00 to $47.00. They now have an "overweight" rating on the stock.
11/18
09:00 am
srrk
Scholar Rock (NASDAQ:SRRK) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $42.00 price target on the stock.
Medium
Report
Scholar Rock (NASDAQ:SRRK) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $42.00 price target on the stock.
11/18
08:00 am
srrk
Scholar Rock to Present at Upcoming Investor Conferences
Medium
Report
Scholar Rock to Present at Upcoming Investor Conferences
11/17
10:23 am
srrk
Scholar Rock (NASDAQ:SRRK) had its price target raised by analysts at Barclays PLC from $44.00 to $45.00. They now have an "overweight" rating on the stock.
Low
Report
Scholar Rock (NASDAQ:SRRK) had its price target raised by analysts at Barclays PLC from $44.00 to $45.00. They now have an "overweight" rating on the stock.
11/16
11:26 am
srrk
Scholar Rock (SRRK) Soars 29% as Drug Candidate Progresses [Yahoo! Finance]
Low
Report
Scholar Rock (SRRK) Soars 29% as Drug Candidate Progresses [Yahoo! Finance]
11/15
07:37 am
srrk
Scholar Rock (SRRK) Climbs 24% on Drug Candidate Progress [Yahoo! Finance]
Low
Report
Scholar Rock (SRRK) Climbs 24% on Drug Candidate Progress [Yahoo! Finance]